PLoS ONE 7 , e36948 (2012)
Subjective assessments of appetite and satiety showed favourable changes, supporting the drugs mechanism of action involving GLP-1 receptor activation
The results of the study we recently published in The Lancet Psychiatry , and reported that GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness absence due to psychiatric reasons
To minimize risks, medications are started at a low dose and increased gradually
Like them or hate them, GLP-1 receptor agonists are undeniably the revolution in weight loss treatment of this generation
European Journal of Obstetrics and Gynecology and Reproductive Biology 2014 , 180 , 148152 [12] Rebouche, C.J